{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:52:32Z","timestamp":1790200352922,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006701","name":"Umm Al-Qura University","doi-asserted-by":"publisher","award":["25UQU4320545GSSR08"],"award-info":[{"award-number":["25UQU4320545GSSR08"]}],"id":[{"id":"10.13039\/501100006701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ijbiomac.2025.146776","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T23:31:31Z","timestamp":1754955091000},"page":"146776","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"P4","title":["2-(Piperidin-1-yl)-N-(4-sulfamoylphenyl)acetamide derivatives as novel inhibitors of cancer-associated carbonic anhydrase isoforms IX and XII"],"prefix":"10.1016","volume":"322","author":[{"given":"Wagdy M.","family":"Eldehna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa M.","family":"Elbadawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainab M.","family":"Elsayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Giovannuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud S.","family":"Elkotamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed E.","family":"Elsawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleh A.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Rashed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Nocentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatem A.","family":"Abdel-Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.ijbiomac.2025.146776_bb0005","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1042\/BCJ20160115","article-title":"Structure and function of carbonic anhydrases","volume":"473","author":"Supuran","year":"2016","journal-title":"Biochem. J."},{"key":"10.1016\/j.ijbiomac.2025.146776_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115538","article-title":"Design and synthesis of 6-arylpyridine-tethered sulfonamides as novel selective inhibitors of carbonic anhydrase IX with promising antitumor features toward the human colorectal cancer","volume":"258","author":"Eldehna","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.146776_bb0015","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1016\/j.bmc.2017.02.037","article-title":"Synthesis of bulky-tailed sulfonamides incorporating pyrido[2,3-d][1,2,4]triazolo[4,3-a]pyrimidin-1(5H)-yl) moieties and evaluation of their carbonic anhydrases I, II, IV and IX inhibitory effects","volume":"25","author":"Fares","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.146776_bb0020","series-title":"Carbonic Anhydrases: Catalytic and Inhibition Mechanisms, Distribution and Physiological Roles","first-page":"13","author":"Supuran","year":"2004"},{"key":"10.1016\/j.ijbiomac.2025.146776_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114412","article-title":"Development of 4-((3-oxo-3-phenylpropyl)amino)benzenesulfonamide derivatives utilizing tail\/dual-tail approaches as novel carbonic anhydrase inhibitors","volume":"238","author":"Elbadawi","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.146776_bb0030","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2174\/138161208783877884","article-title":"Carbonic anhydrases-an overview","volume":"14","author":"Supuran","year":"2008","journal-title":"Curr. Pharm. Des."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.146776_bb0035","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1042\/CS20210040","article-title":"Emerging role of carbonic anhydrase inhibitors","volume":"135","author":"Supuran","year":"2021","journal-title":"Clin. Sci."},{"issue":"22","key":"10.1016\/j.ijbiomac.2025.146776_bb0040","doi-asserted-by":"crossref","first-page":"20438","DOI":"10.1021\/acs.jmedchem.4c01894","article-title":"4-(Pyrazolyl)benzenesulfonamide Ureas as carbonic anhydrases inhibitors and hypoxia-mediated chemo-sensitizing agents in colorectal Cancer cells","volume":"67","author":"Eldehna","year":"2024","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.146776_bb0045","doi-asserted-by":"crossref","first-page":"7406","DOI":"10.1021\/acs.jmedchem.4c00239","article-title":"Discovery and mechanistic studies of dual-target hits for carbonic anhydrase IX and VEGFR-2 as potential agents for solid tumors: X-ray, in vitro, in vivo, and in silico investigations of coumarin-based thiazoles","volume":"67","author":"Hefny","year":"2024","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146776_bb0050","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/sj.bjc.6600936","article-title":"Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer","volume":"89","author":"Potter","year":"2003","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146776_bb0055","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1080\/14756366.2022.2124409","article-title":"Design and synthesis of benzothiazole-based SLC-0111 analogues as new inhibitors for the cancer-associated carbonic anhydrase isoforms IX and XII","volume":"37","author":"Al-Warhi","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"15","key":"10.1016\/j.ijbiomac.2025.146776_bb0060","doi-asserted-by":"crossref","first-page":"10558","DOI":"10.1021\/acs.jmedchem.3c00721","article-title":"1,5-Diaryl-1,2,4-triazole Ureas as new SLC-0111 analogues endowed with dual carbonic anhydrase and VEGFR-2 inhibitory activities","volume":"66","author":"Elsawi","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.146776_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.140462","article-title":"Development of pyrazolo[1,5-a]pyrimidine-grafted coumarins as selective carbonic anhydrase inhibitors and tubulin polymerization inhibitors with potent anticancer activity","volume":"303","author":"Elkotamy","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2025.146776_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117752","article-title":"Rationally designed Pyrazolo[1,5-a]pyrimidines as dual inhibitors of CA IX\/XII and CDK6: a novel approach for NSCLC treatment","volume":"293","author":"Elkotamy","year":"2025","journal-title":"Eur. J. Med. Chem."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.146776_bb0075","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1080\/13543784.2021.2014813","article-title":"Carbonic anhydrase inhibitors: an update on experimental agents for the treatment and imaging of hypoxic tumors","volume":"30","author":"Supuran","year":"2021","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146776_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032937","article-title":"Piperidine derivatives: recent advances in synthesis and pharmacological applications","volume":"24","author":"Frolov","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.146776_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113800","article-title":"Natural inspired piperine-based sulfonamides and carboxylic acids as carbonic anhydrase inhibitors: design, synthesis and biological evaluation","volume":"225","author":"Elimam","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.146776_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.134845","article-title":"Design, synthesis, in vitro and in silico characterization of plastoquinone analogs containing piperidine moiety as antimicrobial agents","volume":"1277","author":"Y\u0131ld\u0131z","year":"2023","journal-title":"J. Mol. Struct."},{"issue":"31","key":"10.1016\/j.ijbiomac.2025.146776_bb0095","doi-asserted-by":"crossref","first-page":"783","DOI":"10.5897\/AJPP2015.4335","article-title":"Antimicrobial and antioxidant activities of piperidine derivatives","volume":"9","author":"Naicker","year":"2015","journal-title":"Afr. J. Pharm. Pharmacol"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.146776_bb0100","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1080\/10406638.2023.2237633","article-title":"Piperidine derivatives: synthesis, pharmacological evaluation and Insilico approach of novel potential analgesics in 4-amino methyl piperidine series","volume":"44","author":"Naseem","year":"2024","journal-title":"Polycycl. Aromat. Compd."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.146776_bb0105","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/j.bmcl.2009.02.070","article-title":"Benzophenone-N-ethyl piperidine ether analogues\u2014synthesis and efficacy as anti-inflammatory agent","volume":"19","author":"Khanum","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.146776_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/neurolint17020026","article-title":"Therapeutic role of heterocyclic compounds in neurodegenerative diseases: insights from Alzheimer's and Parkinson's diseases","volume":"17","author":"Puranik","year":"2025","journal-title":"Neurol. Int."},{"key":"10.1016\/j.ijbiomac.2025.146776_bb0115","first-page":"1","article-title":"Piperidine nucleus in the field of drug discovery","volume":"7","author":"Abdelshaheed","year":"2021","journal-title":"Future J. Pharm. Sci."},{"issue":"42","key":"10.1016\/j.ijbiomac.2025.146776_bb0120","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202401645","article-title":"Anticancer potential of piperidine containing small molecule targeted therapeutics","volume":"9","author":"Saini","year":"2024","journal-title":"ChemistrySelect"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.146776_bb0125","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/01.AOG.0000137349.79204.b8","article-title":"Safety and adverse effects associated with raloxifene: multiple outcomes of raloxifene evaluation","volume":"104","author":"Grady","year":"2004","journal-title":"Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146776_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12030526","article-title":"Efficacy of crizotinib, ceritinib, and alectinib in ALK-positive non-small cell lung cancer treatment: a meta-analysis of clinical trials","volume":"12","author":"Hoang","year":"2020","journal-title":"Cancers"},{"issue":"14","key":"10.1016\/j.ijbiomac.2025.146776_bb0135","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1016\/j.bmcl.2012.05.083","article-title":"Ureido-substituted sulfamates show potent carbonic anhydrase IX inhibitory and antiproliferative activities against breast cancer cell lines","volume":"22","author":"Winum","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ijbiomac.2025.146776_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103728","article-title":"Appliance of the piperidinyl-hydrazidoureido linker to benzenesulfonamide compounds: synthesis, in vitro and in silico evaluation of potent carbonic anhydrase II, IX and XII inhibitors","volume":"98","author":"Moi","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.146776_bb0145","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1021\/acsmedchemlett.3c00484","article-title":"Discovery of a new class of 1-(4-Sulfamoylbenzoyl)piperidine-4-carboxamides as human carbonic anhydrase inhibitors","volume":"15","author":"Moi","year":"2024","journal-title":"ACS Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146776_bb0150","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3390\/molecules28010091","article-title":"Investigation on Hydrazonobenzenesulfonamides as human carbonic anhydrase I, II, IX and XII inhibitors","volume":"28","author":"Moi","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2025.146776_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115707","article-title":"Discovery of indolinone-bearing benzenesulfonamides as new dual carbonic anhydrase and VEGFR-2 inhibitors possessing anticancer and pro-apoptotic properties","volume":"259","author":"Saied","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.146776_bb0160","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ejmech.2014.08.016","article-title":"Improvement of antibacterial activity of some sulfa drugs through linkage to certain phthalazin-1(2H)-one scaffolds","volume":"85","author":"Ibrahim","year":"2014","journal-title":"Eur. J. Med. Chem."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.146776_bb0165","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1021\/acsinfecdis.1c00055","article-title":"Structure\u2013activity relationship studies of acetazolamide-based carbonic anhydrase inhibitors with activity against Neisseria gonorrhoeae","volume":"7","author":"Hewitt","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2025.146776_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.135010","article-title":"Discovery of new sulfonamide-tethered 2-aryl-4-anilinoquinazolines as the first-in-class dual carbonic anhydrase and EGFR inhibitors","volume":"279","author":"Eldehna","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2025.146776_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117706","article-title":"Development of isatin-functionalized benzenesulfonamides as novel carbonic anhydrase II and VII inhibitors with antiepileptic potential","volume":"292","author":"Eldehna","year":"2025","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.146776_bb0180","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1177\/1087057109336751","article-title":"Mechanism-based inhibition: deriving KI and kinact directly from time-dependent IC50 values","volume":"14","author":"Krippendorff","year":"2009","journal-title":"SLAS Dis."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.146776_bb0185","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.70009","article-title":"Molecular docking, DFT and antiproliferative properties of 4-(3,4-dimethoxyphenyl)\u22123-(4-methoxyphenyl)\u22121-phenyl-1H-pyrazolo[3,4-b]pyridine as potent anticancer agent with CDK2 and PIM1 inhibition potency","volume":"85","author":"Binjubair","year":"2024","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ijbiomac.2025.146776_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.140579","article-title":"Exploring antitumor activity of novel imidazo[2,1-b]thiazole and imidazo[1,2-a]pyridine derivatives on MDA-MB-231 cell line: targeting VEGFR-2 enzyme with computational insight","volume":"1322","author":"Elgohary","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ijbiomac.2025.146776_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-13-331","article-title":"Effects of hypoxia on human cancer cell line chemosensitivity","volume":"13","author":"Strese","year":"2013","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146776_bb0200","doi-asserted-by":"crossref","DOI":"10.1038\/srep13605","article-title":"Hypoxia-induced carbonic anhydrase IX facilitates lactate flux in human breast cancer cells by non-catalytic function","volume":"5","author":"Jamali","year":"2015","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146776_bb0205","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1042\/bj20020665","article-title":"Staurosporine induces endothelial cell apoptosis via focal adhesion kinase dephosphorylation and focal adhesion disassembly independent of focal adhesion kinase proteolysis","volume":"367","author":"Kabir","year":"2002","journal-title":"Biochem. J."},{"key":"10.1016\/j.ijbiomac.2025.146776_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117158","article-title":"Design, synthesis, and evaluation of novel benzofuran and pyrazole-based derivatives as dual AChE\/BuChE inhibitors with antioxidant properties for Alzheimer\u2019s disease management","volume":"283","author":"Elkotamy","year":"2025","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146776_bb0215","first-page":"37","article-title":"In silico approaches for rational drug design and potential enzyme inhibitors discovery: a mini-review","volume":"15","author":"Sadeghi","year":"2025","journal-title":"J. Adv. Biomed. Sci."},{"issue":"22","key":"10.1016\/j.ijbiomac.2025.146776_bb0220","doi-asserted-by":"crossref","first-page":"9004","DOI":"10.1021\/acs.jmedchem.5b01343","article-title":"Efficient expression and crystallization system of cancer-associated carbonic anhydrase isoform IX","volume":"58","author":"Leitans","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.146776_bb0225","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bpc.2015.05.009","article-title":"Intrinsic thermodynamics of 4-substituted-2, 3, 5, 6-tetrafluorobenzenesulfonamide binding to carbonic anhydrases by isothermal titration calorimetry","volume":"205","author":"Zubrien\u0117","year":"2015","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.ijbiomac.2025.146776_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116140","article-title":"Developments of small molecules as inhibitors for carbonic anhydrase isoforms","volume":"39","author":"Buabeng","year":"2021","journal-title":"Bioorg. Med. Chem."},{"issue":"19","key":"10.1016\/j.ijbiomac.2025.146776_bb0235","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.1073\/pnas.1520786113","article-title":"Tracking solvent and protein movement during CO2 release in carbonic anhydrase II crystals","volume":"113","author":"Kim","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"13","key":"10.1016\/j.ijbiomac.2025.146776_bb0240","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24132418","article-title":"Synthesis, molecular docking analysis, and carbonic anhydrase inhibitory evaluations of benzenesulfonamide derivatives containing thiazolidinone","volume":"24","author":"Zhang","year":"2019","journal-title":"Molecules"},{"issue":"38","key":"10.1016\/j.ijbiomac.2025.146776_bb0245","doi-asserted-by":"crossref","first-page":"16233","DOI":"10.1073\/pnas.0908301106","article-title":"Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX","volume":"106","author":"Alterio","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.146776_bb0250","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1021\/acs.jmedchem.5b01684","article-title":"Role of molecular dynamics and related methods in drug discovery","volume":"59","author":"De Vivo","year":"2016","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146776_bb0255","first-page":"32","article-title":"Computational modeling of protein dynamics: bridging experimental and theoretical perspectives","volume":"1","author":"Sabri","year":"2024","journal-title":"Multidiscip. J. Biochem."},{"key":"10.1016\/j.ijbiomac.2025.146776_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.139170","article-title":"Sulfonamide-Pyrazole derivatives as next-generation Cyclooxygenase-2 enzyme inhibitors: from molecular design to in vivo efficacy","volume":"293","author":"Elgohary","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2025.146776_bb0265","first-page":"1","article-title":"Design, synthesis and biological evaluation of pyrazolo [3, 4-b] pyridine derivatives as dual CDK2\/PIM1 inhibitors with potent anticancer activity and selectivity","author":"Elkotamy","year":"2025","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ijbiomac.2025.146776_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108247","article-title":"Design, synthesis, and molecular dynamics-driven evaluation of quinoline-sulfonamide derivatives as potent and selective EGFR inhibitors with promising anticancer efficacy and safety profiles","volume":"157","author":"Elkotamy","year":"2025","journal-title":"Bioorg. Chem."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.146776_bb0275","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1021\/acs.jctc.7b00028","article-title":"How molecular size impacts RMSD applications in molecular dynamics simulations","volume":"13","author":"Sargsyan","year":"2017","journal-title":"J. Chem. Theory Comput."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.146776_bb0280","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1021\/acs.jmedchem.9b02090","article-title":"Discovery of potent dual-tailed Benzenesulfonamide inhibitors of human carbonic anhydrases implicated in Glaucoma and in Vivo profiling of their intraocular pressure-lowering action","volume":"63","author":"Fares","year":"2020","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.146776_bb0285","doi-asserted-by":"crossref","first-page":"8873","DOI":"10.1021\/acs.jmedchem.5c00526","article-title":"Shooting an arrow against convulsion: novel Triazole-grafted Benzenesulfonamide derivatives as carbonic anhydrase II and VII inhibitors","volume":"68","author":"Zeidan","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.146776_bb0290","first-page":"1","article-title":"Design, synthesis and biological evaluation of pyrazolo[3,4-b]pyridine derivatives as dual CDK2\/PIM1 inhibitors with potent anticancer activity and selectivity","author":"Elkotamy","year":"2025","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ijbiomac.2025.146776_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108565","article-title":"Development of Benzothiazole-grafted Pyrazolo[1,5-a]pyrimidines as new CDK2 inhibitors and anti-prostate cancer agents","volume":"161","author":"Elkotamy","year":"2025","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146776_bb0300","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1080\/14756366.2022.2070744","article-title":"Discovery of new nicotinamides as apoptotic VEGFR-2 inhibitors: virtual screening, synthesis, antiproliferative, immunomodulatory, ADMET, toxicity, and molecular dynamic simulation studies","volume":"37","author":"Yousef","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.146776_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107644","article-title":"Novel imidazo [2, 1-b] thiazoles and imidazo [1, 2-a] pyridines tethered with indolinone motif as VEGFR-2 inhibitors and apoptotic inducers: design, synthesis and biological evaluations","volume":"151","author":"Elkotamy","year":"2024","journal-title":"Bioorg. Chem."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025073337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025073337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T15:02:30Z","timestamp":1772809350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025073337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":61,"alternative-id":["S0141813025073337"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.146776","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"2-(Piperidin-1-yl)-N-(4-sulfamoylphenyl)acetamide derivatives as novel inhibitors of cancer-associated carbonic anhydrase isoforms IX and XII","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.146776","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"146776"}}